NasdaqGM - Delayed Quote USD

Loncar China BioPharma ETF (CHNA)

13.53 -0.01 (-0.07%)
At close: October 17 at 3:51 PM EDT

ETF Summary

The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

Risk Overview

Performance & Risk

YTD Return 0.29%
5y Average Return 2.04%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.92
Morningstar Risk Rating --

Risk Statistics

3 Years5 Years10 Years
CHNACategory AverageCHNACategory AverageCHNACategory Average
Alpha -20.14 -18.36 -5.99 -6.56 0 -0.7
BETA 0.92 0.91 0.95 0.85 0 0.98
Mean Annual Return -1.27 -1.26 -0.17 0 0 0.38
R-squared 23.69 29.01 30.27 33.27 0 38.47
Standard Deviation 32.68 28.26 30.51 26.48 0 24.05
Sharpe Ratio -0.53 -0.64 -0.13 -0.08 0 0.13
Treynor Ratio -22.36 -22.98 -8.72 -6.64 0 0.28

Related Tickers